Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Equity Average (2018 - 2025)

Historic Equity Average for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $138.6 million.

  • Viemed Healthcare's Equity Average rose 1175.28% to $138.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.6 million, marking a year-over-year increase of 1175.28%. This contributed to the annual value of $123.6 million for FY2024, which is 1716.06% up from last year.
  • Latest data reveals that Viemed Healthcare reported Equity Average of $138.6 million as of Q3 2025, which was up 1175.28% from $139.2 million recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's Equity Average peaked at $139.2 million during Q2 2025, and registered a low of $82.6 million during Q1 2021.
  • Moreover, its 5-year median value for Equity Average was $102.3 million (2023), whereas its average is $107.7 million.
  • Per our database at Business Quant, Viemed Healthcare's Equity Average surged by 7851.13% in 2021 and then surged by 328.56% in 2023.
  • Viemed Healthcare's Equity Average (Quarter) stood at $92.1 million in 2021, then increased by 3.7% to $95.5 million in 2022, then grew by 16.6% to $111.4 million in 2023, then rose by 16.79% to $130.0 million in 2024, then grew by 6.54% to $138.6 million in 2025.
  • Its Equity Average stands at $138.6 million for Q3 2025, versus $139.2 million for Q2 2025 and $135.0 million for Q1 2025.